Skip to content

Pulmonary Hypertension in Connective Tissue Disorders

A Study Of Association of Pulmonary Hypertension in Connective Tissue Disorders - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/063822
Enrollment
77
Registered
2024-03-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M349- Systemic sclerosis, unspecified Health Condition 2: M341- CR(E)ST syndrome Health Condition 3: M342- Systemic sclerosis induced by drugand chemical Health Condition 4: M348- Other forms of systemic sclerosis Health Condition 5: M340- Progressive systemic sclerosis Health Condition 6: M056- Rheumatoid arthritis with involvement of other organs and systems Health Condition 7: M059- Rheumatoid arthritis with rheumatoid factor, unspecified Health Condition 8: M069- Rheumato

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Aditi Rao
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with connective tissue disorders- systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis, sjogrens disease, dermatomyositis, polymyositis, mixed connective tissue disorder, undifferentaited connective tissue disorder, behcets disease

Exclusion criteria

Exclusion criteria: Left Heart disease due to valvular heart disease, congenital heart disease , Chronic lung disease or hypoxia due to chronic obstructive pulmonary disease and sleep disordered breathing, Chronic pulmonary thromboembolism , chronic hemolytic anemia , myeloproliferative disorders, Systemic and metabolic disorders like glycogen storage disease, Gaucher disease, pulmonary Langerhans cell histiocytosis, lymphangioleiomyomatosis, and neurofibromatosis, fibrosing mediastinitis, Portal hypertension, retro viral disease, schistosomiasis or 2D echocardiogram unavailable any time within in the study period.

Design outcomes

Primary

MeasureTime frame
Estimate the frequency of pulmonary hypertension in patients with connective tissue disorderTimepoint: 1 year

Secondary

MeasureTime frame
Compare the severity of pulmonary hypertension with the duration of the connective tissue disorderTimepoint: 1 year;Study the potential clinical and laboratory risk factors for pulmonary hypertension in patients with connective tissue disorderTimepoint: 1 year

Countries

India

Contacts

Public ContactAditi Rao

Department of General Medicine, Kasturba Medical College, Manipal

ram.bhat@manipal.edu9945272251

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026